Annual Cash & Cash Equivalents
$358.33 M
+$196.43 M+121.33%
December 31, 2023
Summary
- As of February 7, 2025, KRYS annual cash & cash equivalents is $358.33 million, with the most recent change of +$196.43 million (+121.33%) on December 31, 2023.
- During the last 3 years, KRYS annual cash & cash equivalents has risen by +$90.06 million (+33.57%).
- KRYS annual cash & cash equivalents is now at all-time high.
Performance
KRYS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$373.97 M
+$28.18 M+8.15%
September 30, 2024
Summary
- As of February 7, 2025, KRYS quarterly cash and cash equivalents is $373.97 million, with the most recent change of +$28.18 million (+8.15%) on September 30, 2024.
- Over the past year, KRYS quarterly cash and cash equivalents has increased by +$725.00 thousand (+0.19%).
- KRYS quarterly cash and cash equivalents is now -7.01% below its all-time high of $402.17 million, reached on March 31, 2021.
Performance
KRYS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
KRYS Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +121.3% | +0.2% |
| 3 y3 years | +33.6% | +131.0% |
| 5 y5 years | +245.6% | +131.0% |
KRYS Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +121.3% | at high | +165.7% |
| 5 y | 5-year | at high | +121.3% | -7.0% | +165.7% |
| alltime | all time | at high | >+9999.0% | -7.0% | >+9999.0% |
Krystal Biotech Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $373.97 M(+8.1%) |
| Jun 2024 | - | $345.79 M(-3.7%) |
| Mar 2024 | - | $359.01 M(+0.2%) |
| Dec 2023 | $358.33 M(+121.3%) | $358.33 M(-4.0%) |
| Sep 2023 | - | $373.24 M(+35.3%) |
| Jun 2023 | - | $275.88 M(+96.0%) |
| Mar 2023 | - | $140.75 M(-13.1%) |
| Dec 2022 | $161.90 M(-52.6%) | $161.90 M(-13.1%) |
| Sep 2022 | - | $186.41 M(-14.8%) |
| Jun 2022 | - | $218.72 M(-18.8%) |
| Mar 2022 | - | $269.30 M(-21.1%) |
| Dec 2021 | $341.25 M(+27.2%) | $341.25 M(+19.1%) |
| Sep 2021 | - | $286.61 M(-13.0%) |
| Jun 2021 | - | $329.53 M(-18.1%) |
| Mar 2021 | - | $402.17 M(+49.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $268.27 M(+43.1%) | $268.27 M(-5.0%) |
| Sep 2020 | - | $282.37 M(-3.2%) |
| Jun 2020 | - | $291.68 M(+61.8%) |
| Mar 2020 | - | $180.22 M(-3.9%) |
| Dec 2019 | $187.51 M(+80.9%) | $187.51 M(-3.7%) |
| Sep 2019 | - | $194.81 M(+4.4%) |
| Jun 2019 | - | $186.59 M(+90.4%) |
| Mar 2019 | - | $98.01 M(-5.5%) |
| Dec 2018 | $103.67 M(+109.1%) | $103.67 M(+122.1%) |
| Sep 2018 | - | $46.67 M(+11.6%) |
| Jun 2018 | - | $41.81 M(-11.5%) |
| Mar 2018 | - | $47.23 M(-4.8%) |
| Dec 2017 | $49.59 M(+2478.8%) | $49.59 M(-5.7%) |
| Sep 2017 | - | $52.57 M(+1394.3%) |
| Jun 2017 | - | $3.52 M(+82.9%) |
| Dec 2016 | $1.92 M | $1.92 M |
FAQ
- What is Krystal Biotech annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Krystal Biotech?
- What is Krystal Biotech annual cash & cash equivalents year-on-year change?
- What is Krystal Biotech quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Krystal Biotech?
- What is Krystal Biotech quarterly cash and cash equivalents year-on-year change?
What is Krystal Biotech annual cash & cash equivalents?
The current annual cash & cash equivalents of KRYS is $358.33 M
What is the all time high annual cash & cash equivalents for Krystal Biotech?
Krystal Biotech all-time high annual cash & cash equivalents is $358.33 M
What is Krystal Biotech annual cash & cash equivalents year-on-year change?
Over the past year, KRYS annual cash & cash equivalents has changed by +$196.43 M (+121.33%)
What is Krystal Biotech quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of KRYS is $373.97 M
What is the all time high quarterly cash and cash equivalents for Krystal Biotech?
Krystal Biotech all-time high quarterly cash and cash equivalents is $402.17 M
What is Krystal Biotech quarterly cash and cash equivalents year-on-year change?
Over the past year, KRYS quarterly cash and cash equivalents has changed by +$725.00 K (+0.19%)